跳至主要内容
临床试验/ITMCTR2024000097
ITMCTR2024000097已完成1 期

Randomized controlled trial of Shuanghuang formula in the treatment of patients with Persistent inflammatory immunosuppressed catabolic syndrome (PICS)

Capital Medical University Affiliated Beijing Traditional Chinese Medicine Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 至 96(—)
性别
All

入选标准

  • (1) Meet the diagnostic criteria for sepsis PICS: presence of infection, SOFA score = 2, and hospitalization for more than 14 days, and fulfillment of at least two of the following three indicators: C-reactive protein (CRP) > 2.0 mg/dL, albumin (Albumin, Alb) < 3.0 g/dL, lymphocytes < 800/µL.
  • (2) Age = 18 years;
  • (3) Voluntarily participate in this study and sign the informed consent form.

排除标准

  • (1) Pregnant or planning to become pregnant;
  • (2) Severe mental illness;
  • (3) Expected survival time of less than 28 days due to underlying diseases, such as uncontrolled malignant tumors or a heart attack within the past 30 days;
  • (4) Vegetative state;
  • (5) Diagnosed or highly suspected of having an acute infectious disease, such as active viral hepatitis or active tuberculosis;
  • (6) Allergy to the active ingredient or excipients of the trial drug;
  • (7) Participated in a clinical intervention trial within the past 3 months.

研究者

发起方
Capital Medical University Affiliated Beijing Traditional Chinese Medicine Hospital

相似试验